{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05856526",
            "orgStudyIdInfo": {
                "id": "1368-0104"
            },
            "secondaryIdInfos": [
                {
                    "id": "2022-501104-10-00",
                    "type": "REGISTRY",
                    "domain": "CTIS (EU)"
                },
                {
                    "id": "U1111-1289-6825",
                    "type": "REGISTRY",
                    "domain": "WHO International Clinical Trials Registry Platform (ICTRP)"
                }
            ],
            "organization": {
                "fullName": "Boehringer Ingelheim",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Netherton Syndrome",
            "officialTitle": "EvasayilTM : A Placebo-controlled Trial to Evaluate the Efficacy and Safety of Spesolimab in the Treatment of Patients With Netherton Syndrome",
            "therapeuticArea": [
                "Rare Diseases"
            ],
            "study": "a-study-to-test-whether-spesolimab-helps-people-with-a-skin-disease-called-netherton-syndrome"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-05-15",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-12-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2028-01-03",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-04-26",
            "studyFirstSubmitQcDate": "2023-05-11",
            "studyFirstPostDateStruct": {
                "date": "2023-05-12",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-10",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-11",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Boehringer Ingelheim",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This study is open to people with a skin disease called Netherton syndrome (NS). People can join the study if they are 12 years and older. The purpose of this study is to find out whether a medicine called spesolimab helps people with NS.\n\nParticipants are divided into a spesolimab and a placebo group. Placebo injections look like spesolimab injections but do not contain any medicine. Every participant has a 2 in 3 chance of being in the spesolimab group. In the beginning, participants get the study medicine as an injection into a vein. Afterwards, they get it as an injection under the skin every month. After 4 months, participants in the placebo group switch to spesolimab treatment.\n\nParticipants are in the study for about 1 year. During this time, they visit the study site 16 times. Where possible, 4 of 16 visits can be done at the participant's home instead of the study site. The doctors regularly check participants' NS symptoms. The results are compared between the groups to see whether spesolimab works. The doctors also regularly check participants' general health and take note of any unwanted effects."
        },
        "conditionsModule": {
            "conditions": [
                "Netherton Syndrome"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2",
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 39,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "interventionNames": [
                        "Drug: Spesolimab - solution for infusion",
                        "Drug: Placebo matching to spesolimab - solution for infusion",
                        "Drug: Spesolimab - solution for injection",
                        "Drug: Placebo matching to spesolimab - solution for injection"
                    ]
                },
                {
                    "label": "Spesolimab",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: Spesolimab - solution for infusion",
                        "Drug: Placebo matching to spesolimab - solution for infusion",
                        "Drug: Spesolimab - solution for injection"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Spesolimab - solution for infusion",
                    "description": "Solution for infusion",
                    "armGroupLabels": [
                        "Placebo",
                        "Spesolimab"
                    ],
                    "otherNames": [
                        "BI 655130"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo matching to spesolimab - solution for infusion",
                    "description": "Solution for infusion",
                    "armGroupLabels": [
                        "Placebo",
                        "Spesolimab"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Spesolimab - solution for injection",
                    "description": "Solution for injection",
                    "armGroupLabels": [
                        "Placebo",
                        "Spesolimab"
                    ],
                    "otherNames": [
                        "BI 655130"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo matching to spesolimab - solution for injection",
                    "description": "Solution for injection",
                    "armGroupLabels": [
                        "Placebo"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "IASI response",
                    "description": "Ichthyosis Area Severity Index (IASI) response is defined as a decrease of at least 50 % absolute change in IASI score from baseline at Week 16.",
                    "timeFrame": "At baseline and at Week 16."
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Key secondary endpoint: IGA response",
                    "description": "Investigator Global Assessment (IGA)",
                    "timeFrame": "at Week 16."
                },
                {
                    "measure": "IGA response",
                    "description": "Investigator Global Assessment (IGA)",
                    "timeFrame": "up to Week 12."
                },
                {
                    "measure": "IASI response",
                    "description": "Ichthyosis Area Severity Index (IASI)",
                    "timeFrame": "At baseline and up to Week 12."
                },
                {
                    "measure": "IASI-E subscore response",
                    "description": "Ichthyosis Area Severity Index - Erythema (IASI-E)",
                    "timeFrame": "At baseline and up to Week 16."
                },
                {
                    "measure": "IASI-S subscore response",
                    "description": "Ichthyosis Area Severity Index - Scaling (IASI-S)",
                    "timeFrame": "At baseline and up to Week 16"
                },
                {
                    "measure": "Percent change from baseline in IASI score",
                    "description": "Ichthyosis Area Severity Index (IASI)",
                    "timeFrame": "At baseline and up to Week 16."
                },
                {
                    "measure": "Absolute change from baseline in NRS pain",
                    "description": "The Numeric Pain Rating Scale (NRS)",
                    "timeFrame": "At baseline and up to Week 16."
                },
                {
                    "measure": "Absolute change from baseline in NRS itch",
                    "description": "The Numeric Rating Scale (NRS)",
                    "timeFrame": "At baseline and up to Week 16."
                },
                {
                    "measure": "Absolute change from baseline in DLQI/CDLQI score",
                    "description": "Dermatology Life Quality Index (DLQI)/Children Dermatology Life Quality Index (CDLQI)",
                    "timeFrame": "At baseline and up to Week 16."
                },
                {
                    "measure": "The occurrence of treatment emergent adverse events including serious and/or opportunistic infections",
                    "timeFrame": "up to 172 weeks."
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Male or female patients, aged 12 years and older (weight minimum is 35kg).\n* Confirmed diagnosis of Netherton syndrome (NS) (causative SPINK5 mutations) at baseline (Visit 2).\n* At least moderate severity of erythema at baseline (visit 2) (Ichthyosis Area Severity Index (IASI) score \u2265 16 and IASI-Erythema (E) score \u22658) and \u2265 3 on Investigator Global Assessment (IGA) score.\n* Signed and dated written informed consent and assent in accordance with International Council on Harmonisation-Good Clinical Practice (ICH-GCP) and local legislation prior to admission in the trial\n* Women of childbearing potential (WOCBP) must be ready and able to use highly effective methods of birth control per ICH M3 (R2) that result in a low failure rate of less than 1% per year when used consistently and correctly. A list of contraception methods meeting these criteria is provided in the clinical trial protocol (CTP) as well as in the patient, parent(s) (or patient's legal guardian) information.\n\nExclusion Criteria:\n\n* Patients who have used topical corticosteroids (medium to high, US class I-V), topical retinoids, topical calcineurin inhibitors or keratolytics within 1 week prior to randomisation\n* Patients who have used emollient on the area to be biopsied in the previous 24 hours\n* Patients who have used systemic retinoids, other systemic immunosuppressants, systemic corticosteroids or phototherapy within 4 weeks prior to randomisation\n* Patients who have used systemic antibiotics within 2 weeks prior to randomisation\n* Patients who have received live vaccines within 4 weeks prior to randomisation\n* Patients who have received investigational products, biologics or immunoglobulins within 4 weeks or 5 half-lives (whichever is longer) prior to randomisation\n* Severe, progressive, or uncontrolled hepatic disease, defined as \\>3-fold Upper Limit of Normal (ULN) elevation in Aspartate Aminotransferase (AST) or Alanine Aminotransferase (ALT) or alkaline phosphatase, or \\>2-fold ULN elevation in total bilirubin\n* Patients who have any prior exposure to BI 655130 or another interleukin 36 receptor (IL-36R) inhibitor biologics\n* Further exclusion criteria apply",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "12 Years",
            "stdAges": [
                "CHILD",
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Boehringer Ingelheim",
                    "role": "CONTACT",
                    "phone": "1-800-243-0127",
                    "email": "clintriage.rdg@boehringer-ingelheim.com"
                }
            ],
            "locations": [
                {
                    "facility": "Mission Dermatology Center",
                    "status": "RECRUITING",
                    "city": "Rancho Santa Margarita",
                    "state": "California",
                    "zip": "92688",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "833-602-2368",
                            "email": "unitedstates@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.64086,
                        "lon": -117.6031
                    }
                },
                {
                    "facility": "Yale University School of Medicine",
                    "status": "RECRUITING",
                    "city": "New Haven",
                    "state": "Connecticut",
                    "zip": "06519",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "833-602-2368",
                            "email": "unitedstates@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.30815,
                        "lon": -72.92816
                    }
                },
                {
                    "facility": "Virginia Clinical Research, Inc.",
                    "status": "RECRUITING",
                    "city": "Norfolk",
                    "state": "Virginia",
                    "zip": "23502",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "833-602-2368",
                            "email": "unitedstates@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 36.84681,
                        "lon": -76.28522
                    }
                },
                {
                    "facility": "Westmead Hospital",
                    "status": "RECRUITING",
                    "city": "Westmead",
                    "state": "New South Wales",
                    "zip": "2145",
                    "country": "Australia",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "1800271035",
                            "email": "australia@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": -33.80383,
                        "lon": 150.98768
                    }
                },
                {
                    "facility": "UZ Leuven",
                    "status": "RECRUITING",
                    "city": "Leuven",
                    "zip": "3000",
                    "country": "Belgium",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "080049616",
                            "email": "belgique@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 50.87959,
                        "lon": 4.70093
                    }
                },
                {
                    "facility": "ASMC-IPSMC-skin and Veneral Diseases",
                    "status": "RECRUITING",
                    "city": "Sofia",
                    "zip": "1407",
                    "country": "Bulgaria",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "024903378",
                            "email": "balgariya@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.69751,
                        "lon": 23.32415
                    }
                },
                {
                    "facility": "Beijing Children's Hospital, Capital Medical University",
                    "status": "RECRUITING",
                    "city": "Beijing",
                    "zip": "100045",
                    "country": "China",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "4001200553",
                            "email": "china@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.9075,
                        "lon": 116.39723
                    }
                },
                {
                    "facility": "Southern Medical University Dermatology Hospital",
                    "status": "RECRUITING",
                    "city": "Guangzhou",
                    "zip": "510091",
                    "country": "China",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "4001200553",
                            "email": "china@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 23.11667,
                        "lon": 113.25
                    }
                },
                {
                    "facility": "The Children's Hospital Zhejiang University School Of Medicine",
                    "status": "RECRUITING",
                    "city": "Hangzhou",
                    "zip": "310000",
                    "country": "China",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "4001200553",
                            "email": "china@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 30.29365,
                        "lon": 120.16142
                    }
                },
                {
                    "facility": "The First Affiliated Hospital, Zhejiang University",
                    "status": "RECRUITING",
                    "city": "Hangzhou",
                    "zip": "310003",
                    "country": "China",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "4001200553",
                            "email": "china@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 30.29365,
                        "lon": 120.16142
                    }
                },
                {
                    "facility": "Dermatology Hospital, Chinese Academy of Medical Sciences",
                    "status": "RECRUITING",
                    "city": "Nanjing",
                    "zip": "210000",
                    "country": "China",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "4001200553",
                            "email": "china@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.06167,
                        "lon": 118.77778
                    }
                },
                {
                    "facility": "Shanghai Skin Disease Hospital",
                    "status": "RECRUITING",
                    "city": "Shanghai",
                    "zip": "200000",
                    "country": "China",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "4001200553",
                            "email": "china@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 31.22222,
                        "lon": 121.45806
                    }
                },
                {
                    "facility": "Xinhua Hospital Affiliated to Shanghai Jiaotong University",
                    "status": "RECRUITING",
                    "city": "Shanghai",
                    "zip": "200092",
                    "country": "China",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "4001200553",
                            "email": "china@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 31.22222,
                        "lon": 121.45806
                    }
                },
                {
                    "facility": "Suomen Terveystalo oy Tampere",
                    "status": "RECRUITING",
                    "city": "Tampere",
                    "zip": "33100",
                    "country": "Finland",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "0800918118",
                            "email": "suomi@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 61.49911,
                        "lon": 23.78712
                    }
                },
                {
                    "facility": "HOP Saint-Louis",
                    "status": "RECRUITING",
                    "city": "Paris",
                    "zip": "75010",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "0805102354",
                            "email": "france@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 48.85341,
                        "lon": 2.3488
                    }
                },
                {
                    "facility": "Universit\u00e4tsklinikum Erlangen",
                    "status": "RECRUITING",
                    "city": "Erlangen",
                    "zip": "91054",
                    "country": "Germany",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "08007234742",
                            "email": "deutschland@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 49.59099,
                        "lon": 11.00783
                    }
                },
                {
                    "facility": "Universit\u00e4tsklinikum Heidelberg",
                    "status": "RECRUITING",
                    "city": "Heidelberg",
                    "zip": "69120",
                    "country": "Germany",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "08007234742",
                            "email": "deutschland@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 49.40768,
                        "lon": 8.69079
                    }
                },
                {
                    "facility": "Universit\u00e4tsklinikum Schleswig-Holstein, Campus Kiel",
                    "status": "RECRUITING",
                    "city": "Kiel",
                    "zip": "24105",
                    "country": "Germany",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "08007234742",
                            "email": "deutschland@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 54.32133,
                        "lon": 10.13489
                    }
                },
                {
                    "facility": "Klinikum der Universit\u00e4t M\u00fcnchen A\u00d6R",
                    "status": "RECRUITING",
                    "city": "M\u00fcnchen",
                    "zip": "80337",
                    "country": "Germany",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "08007234742",
                            "email": "deutschland@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 48.13743,
                        "lon": 11.57549
                    }
                },
                {
                    "facility": "Sourasky Medical Center",
                    "status": "RECRUITING",
                    "city": "Tel Aviv",
                    "zip": "6423906",
                    "country": "Israel",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "1809388162",
                            "email": "israel@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.08088,
                        "lon": 34.78057
                    }
                },
                {
                    "facility": "Istituto Dermopatico Dell'Immacolata - IDI - IRCCS",
                    "status": "RECRUITING",
                    "city": "Roma",
                    "zip": "00167",
                    "country": "Italy",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "800977373",
                            "email": "italia@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.89193,
                        "lon": 12.51133
                    }
                },
                {
                    "facility": "AO Citt\u00e0 della Salute e Scienza",
                    "status": "RECRUITING",
                    "city": "Torino",
                    "zip": "10126",
                    "country": "Italy",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "800977373",
                            "email": "italia@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 45.07049,
                        "lon": 7.68682
                    }
                },
                {
                    "facility": "Nagoya University Hospital",
                    "status": "RECRUITING",
                    "city": "Aichi, Nagoya",
                    "zip": "466-8560",
                    "country": "Japan",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "0120201230",
                            "email": "nippon@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.51879,
                        "lon": 130.62158
                    }
                },
                {
                    "facility": "Juntendo University Urayasu Hospital",
                    "status": "RECRUITING",
                    "city": "Chiba, Urayasu",
                    "zip": "279-0021",
                    "country": "Japan",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "0120201230",
                            "email": "nippon@bitrialsupport.com"
                        }
                    ]
                },
                {
                    "facility": "Okayama University Hospital",
                    "status": "RECRUITING",
                    "city": "Okayama, Okayama",
                    "zip": "700-8558",
                    "country": "Japan",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "0120201230",
                            "email": "nippon@bitrialsupport.com"
                        }
                    ]
                },
                {
                    "facility": "Hospital Tunku Azizah",
                    "status": "RECRUITING",
                    "city": "Kuala Lumpur",
                    "zip": "50300",
                    "country": "Malaysia",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "1800814353",
                            "email": "malaysia@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 3.1412,
                        "lon": 101.68653
                    }
                },
                {
                    "facility": "Sunway Medical Centre",
                    "status": "RECRUITING",
                    "city": "Selangor Darul Ehsan",
                    "zip": "47500",
                    "country": "Malaysia",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "1800814353",
                            "email": "malaysia@bitrialsupport.com"
                        }
                    ]
                },
                {
                    "facility": "Erasmus MC - Sophia Kinderziekenhuis",
                    "status": "RECRUITING",
                    "city": "Rotterdam",
                    "zip": "3015 GD",
                    "country": "Netherlands",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "08000204613",
                            "email": "nederland@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 51.9225,
                        "lon": 4.47917
                    }
                },
                {
                    "facility": "ULS de S\u00e3o Jos\u00e9, E.P.E. - Hospital Sto. Ant\u00f3nio Capuchos",
                    "status": "RECRUITING",
                    "city": "Lisboa",
                    "zip": "1169-050",
                    "country": "Portugal",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "800856070",
                            "email": "portugal@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.71667,
                        "lon": -9.13333
                    }
                },
                {
                    "facility": "University Children Hospital Z\u00fcrich",
                    "status": "RECRUITING",
                    "city": "Z\u00fcrich",
                    "zip": "8032",
                    "country": "Switzerland",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "0800005900",
                            "email": "suisse@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 47.36667,
                        "lon": 8.54999
                    }
                },
                {
                    "facility": "Queen Elizabeth University Hospital",
                    "status": "RECRUITING",
                    "city": "Glasgow",
                    "zip": "G51 4TF",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "08000514022",
                            "email": "unitedkingdom@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 55.86515,
                        "lon": -4.25763
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "Related Info",
                    "url": "http://www.mystudywindow.com"
                },
                {
                    "label": "Related Info",
                    "url": "https://www.firstskinfoundation.org/netherton-study-bi"
                },
                {
                    "label": "Related Info",
                    "url": "https://www.firstskinfoundation.org/userAssets/file/33023532_EVASAYIL_NS_Patient_info_sheet_US.pdf"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "Once the criteria in section \"Time Frame\" are fulfilled, researchers can use the following link https://www.mystudywindow.com/msw/datasharing to request access to the clinical study documents regarding this study, and upon a signed \"Document Sharing Agreement\".\n\nFurthermore, researchers can request access to the clinical study data, for this and other listed studies, after the submission of a research proposal and according to the terms outlined in the website.",
            "infoTypes": [
                "STUDY_PROTOCOL",
                "SAP",
                "CSR"
            ],
            "timeFrame": "After structured results have been posted, all regulatory activities are completed in the US and EU for the product and indication, and after the primary manuscript has been accepted for publication.",
            "accessCriteria": "For study documents - upon signing of a 'Document Sharing Agreement'. For study data - 1. after the submission and approval of the research proposal (checks will be performed by the sponsor and/or the independent review panel, including checking that the planned analysis does not compete with sponsor's publication plan); 2. and upon signing of a legal agreement.",
            "url": "https://www.mystudywindow.com/msw/datasharing"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30",
            "removedCountries": [
                "Austria"
            ]
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000056770",
                    "term": "Netherton Syndrome"
                },
                {
                    "id": "D000013577",
                    "term": "Syndrome"
                }
            ],
            "ancestors": [
                {
                    "id": "D000004194",
                    "term": "Disease"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000000015",
                    "term": "Abnormalities, Multiple"
                },
                {
                    "id": "D000000013",
                    "term": "Congenital Abnormalities"
                },
                {
                    "id": "D000016113",
                    "term": "Ichthyosiform Erythroderma, Congenital"
                },
                {
                    "id": "D000007057",
                    "term": "Ichthyosis"
                },
                {
                    "id": "D000012868",
                    "term": "Skin Abnormalities"
                },
                {
                    "id": "D000012873",
                    "term": "Skin Diseases, Genetic"
                },
                {
                    "id": "D000030342",
                    "term": "Genetic Diseases, Inborn"
                },
                {
                    "id": "D000007232",
                    "term": "Infant, Newborn, Diseases"
                },
                {
                    "id": "D000007642",
                    "term": "Keratosis"
                },
                {
                    "id": "D000012871",
                    "term": "Skin Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M16355",
                    "name": "Syndrome",
                    "asFound": "Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "M15674",
                    "name": "Skin Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M28589",
                    "name": "Netherton Syndrome",
                    "asFound": "Netherton Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12",
                    "name": "Congenital Abnormalities",
                    "relevance": "LOW"
                },
                {
                    "id": "M14",
                    "name": "Abnormalities, Multiple",
                    "relevance": "LOW"
                },
                {
                    "id": "M7068",
                    "name": "Dermatitis, Exfoliative",
                    "relevance": "LOW"
                },
                {
                    "id": "M18591",
                    "name": "Ichthyosiform Erythroderma, Congenital",
                    "relevance": "LOW"
                },
                {
                    "id": "M10106",
                    "name": "Ichthyosis",
                    "relevance": "LOW"
                },
                {
                    "id": "M15672",
                    "name": "Skin Abnormalities",
                    "relevance": "LOW"
                },
                {
                    "id": "M15676",
                    "name": "Skin Diseases, Genetic",
                    "relevance": "LOW"
                },
                {
                    "id": "M23686",
                    "name": "Genetic Diseases, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "M10276",
                    "name": "Infant, Newborn, Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M28268",
                    "name": "Keratosis, Actinic",
                    "relevance": "LOW"
                },
                {
                    "id": "M10668",
                    "name": "Keratosis",
                    "relevance": "LOW"
                },
                {
                    "id": "T4080",
                    "name": "Netherton Syndrome",
                    "asFound": "Netherton Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "T2984",
                    "name": "Ichthyosis Linearis Circumflexa",
                    "asFound": "Netherton Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "T2153",
                    "name": "Exfoliative Dermatitis",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000019999",
                    "term": "Pharmaceutical Solutions"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M21860",
                    "name": "Pharmaceutical Solutions",
                    "asFound": "Procedure",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "PhSol",
                    "name": "Pharmaceutical Solutions"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}